Invivyd, Inc. (IVVD) stock
IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3045% below fair value
$0.51−0.03 (-4.67%)
Close on Nov 17, 2026Market cap $151.09MP/E –Yield –
Invivyd enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Invivyd's enterprise value was $16.57M on Nov 11, 2026, against $436.05M a year earlier. Over the last 5 years it ranged from -$225.38M to $444.62M, with a median of $37.69M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.57M | -96.3% |
| 2025 | Dec 31, 2025 | $444.62M | – |
| 2024 | Dec 31, 2024 | -$53.87M | -121.5% |
| 2023 | Dec 29, 2023 | $250.97M | – |
| 2022 | Dec 30, 2022 | -$114.72M | -134.8% |
| 2021 | Dec 31, 2021 | $329.42M | – |
See a number that looks wrong?